Straumann Group’s core net profit fell to CHF 266 million in the first half of 2025 from CHF 281 million a year earlier, as currency headwinds offset higher revenue, the company said Wednesday.
The Switzerland-based dental implant and orthodontics company reported revenue of CHF 1.3 billion for the six months ended June 30, up 10.2% organically and 5.9% in Swiss francs from the prior-year period.
Second-quarter revenue was CHF 667.5 million, a 9.3% organic increase and 1.9% higher in Swiss francs, with growth in all regions.
The core EBIT margin was 27.3% at constant 2024 exchange rates and 26.6% at current rates.
The company cited unfavorable movements in the U.S. dollar, Chinese renminbi and Brazilian real as the main currency impacts in the second quarter.
First-half core gross profit rose to CHF 972 million, with a margin of 72.1%. Currency effects reduced the gross margin by 50 basis points from last year, which the company said was offset by a favorable product mix.
Core EBIT increased year over year to CHF 358 million, with the margin down 130 basis points, including a 90 basis point reduction from currency effects.
Free cash flow fell to CHF 113 million from CHF 145 million in the first half of 2024, mainly due to CHF 113 million in capital expenditure, which was CHF 29 million higher than a year earlier.
Investments included manufacturing expansion in Brazil and Germany and the new Shanghai campus, which began producing Straumann implants for the Chinese market.
In the second quarter, EMEA revenue rose 8.2% organically to CHF 270.4 million, led by Germany, Spain, Turkey and Eastern Europe.
North America revenue increased 2.7% organically to CHF 170.7 million, with slower growth in orthodontics.
Asia-Pacific revenue rose 16.4% organically to CHF 169.3 million, supported by growth in China, Australia, Japan, India and Thailand. Latin America posted 16.2% organic growth to CHF 57.1 million, led by Brazil and Mexico.
Product launches during the period included the iEXCEL implant system, the Straumann AXS digital platform, the SIRIOS intraoral scanner and the MIDAS 3D printer.
The company also acquired the remaining 51% of German ceramic implant maker maxon dental GmbH, taking full ownership.
Straumann confirmed its full-year 2025 outlook, targeting high single-digit organic revenue growth and a 30 to 60 basis point improvement in the core EBIT margin at constant 2024 exchange rates.
Source :
https://www.investing.com/news/earnings/straumann-group-profit-falls-on-currency-headwinds-despite-revenue-growth-4187132
